Novartis pauses autoimmune cell therapy studies after deaths
Novartis has paused its autoimmune cell therapy studies following deaths.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.